Sleep Apnea, Obstructive Completed Phase 4 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01344759Dexmedetomidine and Propofol in Children With History of Obstructive Sleep ApneaTreatment